University Children's Hospital Tuebingen
- Country
- 🇩🇪Germany
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT03559413
- Locations
- 🇩🇪
University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany
🇩🇪University Medical Center for Children and Adolescents Heidelberg, Heidelberg, Baden-Württemberg, Germany
🇩🇪University Hospital Düsseldorf, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Düsseldorf, Nordrhein-Westfalen, Germany
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma
- First Posted Date
- 2014-10-07
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 35
- Registration Number
- NCT02258815
- Locations
- 🇦🇹
University Hospital Graz, Graz, Austria
🇦🇹St. Anna Childrens Hospital, Vienna, Austria
🇩🇪University Hospital Greifswald, Greifswald, Germany
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells
- Conditions
- Interventions
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 120
- Registration Number
- NCT01919866
- Locations
- 🇩🇪
University Children's Hospital, Tuebingen, Germany
🇩🇪Medizinische Hochschule Zentrum für Kinderheilkunde, Hannover, Germany
Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT01309178
- Locations
- 🇩🇪
Lutz Naehrlich, Giessen, Germany
🇩🇪Joachim Riethmueller, Tuebingen, Germany
🇩🇪Jochen Mainz, Jena, Germany
Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation
- Conditions
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- University Children's Hospital Tuebingen
- Registration Number
- NCT01040156
- Locations
- 🇩🇪
University Children's Hospital, Tuebingen, Germany
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 863
- Registration Number
- NCT01035190
- Locations
- 🇨🇿
University Hospital of Tomas Bati, Department of Neonatology, Zlin, Czech Republic
🇫🇮Tampere University Hospita, NICU, Tampere, Finland
🇳🇱Erasmus MC - Sophia, Department of Neonatology, Rotterdam, Netherlands